Intuitive Surgical, Inc. $ISRG Holdings Lifted by Generali Investments CEE investicni spolecnost a.s.

Generali Investments CEE investicni spolecnost a.s. increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 82.9% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 1,516 shares of the medical equipment provider’s stock after purchasing an additional 687 shares during the quarter. Generali Investments CEE investicni spolecnost a.s.’s holdings in Intuitive Surgical were worth $824,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of ISRG. Nuveen LLC purchased a new position in shares of Intuitive Surgical during the first quarter valued at $1,715,899,000. Goldman Sachs Group Inc. grew its holdings in shares of Intuitive Surgical by 26.1% during the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock valued at $1,396,496,000 after buying an additional 584,375 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Intuitive Surgical by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock valued at $1,680,922,000 after buying an additional 566,979 shares in the last quarter. Wellington Management Group LLP grew its holdings in shares of Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after buying an additional 457,080 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in Intuitive Surgical by 1.4% in the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after purchasing an additional 453,335 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 45,224 shares of company stock valued at $21,716,492. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $447.23 on Wednesday. The company has a market cap of $160.32 billion, a PE ratio of 62.38, a price-to-earnings-growth ratio of 4.60 and a beta of 1.61. The stock has a 50-day moving average of $466.61 and a 200-day moving average of $500.97. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the prior year, the company posted $1.78 EPS. The firm’s revenue was up 21.4% on a year-over-year basis. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts have commented on ISRG shares. Royal Bank Of Canada restated an “outperform” rating and issued a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Friday, September 26th. BTIG Research boosted their target price on Intuitive Surgical from $566.00 to $571.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. Truist Financial boosted their target price on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. Finally, Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $595.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.